Cobicistat + Elvitegravir + Emtricitabine + Tenofovir Disoproxil

Fixed-dose combination

This page lists brands whose active-ingredient set is exactly the combination below. It is identity information only — a fixed-dose combination is not the same product as its single ingredients, and the brand names are not interchangeable across markets.

Not medical advice. Check the pack and the exact composition before comparing products; ask a pharmacist if unsure.

Active ingredients

Brands with this exact combination

BrandComposition & strengthManufacturer
Elvitegravir 150mg / Cobicistat 150mg / Emtricitabine 200mg / Tenofovir disoproxil 245mg tabletsES GB150 mg / 200 mg / 245 mgGilead Sciences Ireland Unlimited Company
elvitegravir + cobicistat + emtricitabina + tenofovirES150 mg / 200 mg / 245 mgGilead Sciences Ireland Unlimited Company
elvitegravir, cobicistat, emtricitabine, and tenofovir disoproxil fumarateUS150 mg / 200 mg / 300 mgGilead Sciences, Inc.
elvitegravir + cobicistat + tenofovir disoproxil fumarate + emtricitabineAU——
STRIBILD tenofovir disoproxil fumarate 300mg, emtricitabine 200 mg, elvitegravir 150 mg, cobicistat 150 mg tablet bottleAU
  • tablet Cobicistat 150 mg + Elvitegravir 150 mg + Emtricitabine 200 mg + Tenofovir Disoproxil 300 mg
Gilead Sciences Pty Ltd

Same combination in other markets

These markets record products with the same active-ingredient combination. Identity only — not a recommendation that products are interchangeable.

See warnings for these ingredients

Source & licence: built from the same regulator data as the ingredient pages (openFDA, dm+d, CIMA, COFEPRIS, PBS/TGA, Health Canada DPD, NHSA). Facts only; see the licence register.